- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
Patent holdings for IPC class C12N 9/24
Total number of patents in this class: 3292
10-year publication summary
|
269
|
246
|
279
|
236
|
238
|
226
|
222
|
252
|
212
|
77
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novozymes A/S | 3346 |
315 |
| DSM IP Assets B.V. | 5430 |
77 |
| Novozymes, Inc. | 280 |
65 |
| Danisco US Inc. | 1123 |
63 |
| The Regents of the University of California | 20556 |
38 |
| IFP Energies Nouvelles | 3034 |
35 |
| BASF SE | 21129 |
33 |
| The Trustees of the University of Pennsylvania | 4406 |
30 |
| Modernatx, Inc. | 1280 |
30 |
| Vib VZW | 888 |
27 |
| Danstar Ferment AG | 1018 |
23 |
| Codexis, Inc. | 817 |
22 |
| International N&h Denmark ApS | 390 |
22 |
| Takeda Pharmaceutical Company Limited | 2721 |
21 |
| JCR Pharmaceuticals Co., Ltd. | 227 |
20 |
| President and Fellows of Harvard College | 6044 |
19 |
| Korea University Research and Business Foundation | 3178 |
19 |
| Centre National de La Recherche Scientifique | 10881 |
18 |
| Amicus Therapeutics, Inc. | 356 |
18 |
| Regeneron Pharmaceuticals, Inc. | 4608 |
18 |
| Other owners | 2379 |